Antibodies blocking the major pro-inflammatory cytokine TNFα can cause new-onset neurologic symptoms in rheumatoid arthritis patients, associated with demyelinating lesions of the CNS [10,11], and may elicit immunogenic responses [12]. Here, TNF is linked to rheumatoid arthritis.